NEURAPRO: A multi-centre RCT of omega-3 polyunsaturated fatty acids versus placebo in young people at ultra-high risk of psychotic disorders - Medium-term follow-up and clinical course
Version 3 2024-06-19, 02:45Version 3 2024-06-19, 02:45
Version 2 2024-06-05, 11:20Version 2 2024-06-05, 11:20
Version 1 2021-05-10, 16:08Version 1 2021-05-10, 16:08
journal contribution
posted on 2024-06-19, 02:45authored byB Nelson, GP Amminger, HP Yuen, C Markulev, S Lavoie, MR Schäfer, JA Hartmann, N Mossaheb, M Schlögelhofer, S Smesny, IB Hickie, G Berger, EYH Chen, L De Haan, DH Nieman, M Nordentoft, A Riecher-Rössler, S Verma, A Thompson, Alison YungAlison Yung, PD McGorry
NEURAPRO: A multi-centre RCT of omega-3 polyunsaturated fatty acids versus placebo in young people at ultra-high risk of psychotic disorders - Medium-term follow-up and clinical course